Status:
COMPLETED
Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd
Conditions:
Drug-Drug Interaction
Eligibility:
MALE
19-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the Drug interaction and safety of Fimasartan/Amlodipine and Hydrochlorothiazide in Healthy Male volunteers.
Eligibility Criteria
Inclusion
- A healthy Male adults aged 19-50 years
Exclusion
- History or presence of clinically significant medical or psychiatric condition or disease.
- Hypersensitivity to ingredient of IP and other medication, food.
- Participation in any other study within 3months.
- History of whole blood donation within 2months and Apheresis 1month.
Key Trial Info
Start Date :
December 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2018
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT03390465
Start Date
December 15 2017
End Date
January 30 2018
Last Update
August 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inje University Busan Paik Hospital
Busan, South Korea